Emerging-markets stocks have been mostly submerging the past
year or so. But Baron Emerging Markets fund has managed to stay
afloat and deliver a respectable return. The fund has also excelled
against the competition, beating 96% of diversified
emerging-markets funds over the past 12 months.Manager Michael Kass credits Baron's philosophy of deeply
researching companies for the successful run. Doing his homework
helped him find such obscure companies as Shuaa Capital, a United
Arab Emirates financial firm (and the fund's only holding in
so-called frontier markets); Steinhoff International, a South
African furniture maker; and China's Sihuan Pharmaceutical. All
three stocks have at least doubled over the past year.
http://tinyurl.com/qdven9u
Igor Purlantov is an expert on business and politics across emerging markets. Mr. Purlantov has worked extensively in various emerging countries throughout Europe, Asia and Africa with both public and private companies as well as local governments. You can read and learn more about his work on www.igor-purlantov.net
Showing posts with label china's sihuan pharmaceutical. Show all posts
Showing posts with label china's sihuan pharmaceutical. Show all posts
Monday, June 16, 2014
Subscribe to:
Posts (Atom)